|
1
|
Cameron AM: Screening for viral hepatitis
and hepatocellular cancer. Surg Clin North Am. 95:1013–1021. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tomizawa M, Kondo F and Kondo Y: Growth
patterns and interstitial invasion of small hepatocellular
carcinoma. Pathol Int. 45:352–358. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leffert HL and Paul D: Studies on primary
cultures of differentiated fetal liver cells. J Cell Biol.
52:559–568. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohira RH, Dipple KM, Zhang YH and McCabe
ER: Human and murine glycerol kinase: Influence of exon 18
alternative splicing on function. Biochem Biophys Res Commun.
331:239–246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ai Y, Jenkins NA, Copeland NG, Gilbert DH,
Bergsma DJ and Stambolian D: Mouse galactokinase: Isolation,
characterization, and location on chromosome 11. Genome Res.
5:53–59. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wheatley DN, Scott L, Lamb J and Smith S:
Single amino acid (arginine) restriction: Growth and death of
cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem.
10:37–55. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomizawa M, Toyama Y, Ito C, Toshimori K,
Iwase K, Takiguchi M, Saisho H and Yokosuka O: Hepatoblast-like
cells enriched from mouse embryonic stem cells in medium without
glucose, pyruvate, arginine, and tyrosine. Cell Tissue Res.
333:17–27. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Survival of primary human
hepatocytes and death of induced pluripotent stem cells in media
lacking glucose and arginine. PLoS One. 8:e718972013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghosn MG, Tuchin VV and Larin KV:
Depth-resolved monitoring of glucose diffusion in tissues by using
optical coherence tomography. Opt Lett. 31:2314–2316. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomizawa M, Garfield S, Factor V and
Xanthopoulos KG: Hepatocytes deficient in CCAAT/enhancer binding
protein alpha (C/EBP alpha) exhibit both hepatocyte and biliary
epithelial cell character. Biochem Biophys Res Commun. 249:1–5.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tomizawa M, Wang YQ, Ebara M, Saisho H,
Watanabe K, Nakagawara A and Tagawa M: Decreased expression of the
CCAAT/enhancer binding protein alpha gene involved in hepatocyte
proliferation in human hepatocellular carcinomas. Int J Mol Med.
9:597–600. 2002.PubMed/NCBI
|
|
12
|
Guzman G, Alagiozian-Angelova V,
Layden-Almer JE, Layden TJ, Testa G, Benedetti E, Kajdacsy-Balla A
and Cotler SJ: p53, Ki-67, and serum alpha feto-protein as
predictors of hepatocellular carcinoma recurrence in liver
transplant patients. Mod Pathol. 18:1498–1503. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Orian-Rousseau V and Sleeman J: CD44 is a
multidomain signaling platform that integrates extracellular matrix
cues with growth factor and cytokine signals. Adv Cancer Res.
123:231–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hiraga T, Ito S and Nakamura H: Cancer
stem-like cell marker CD44 promotes bone metastases by enhancing
tumorigenicity, cell motility and hyaluronan production. Cancer
Res. 73:4112–4122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim R, Kim SB, Cho EH, Park SH, Park SB,
Hong SK and Chae G: CD44 expression in patients with combined
hepatocellular cholangiocarcinoma. Ann Surg Treat Res. 89:9–16.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Friemel J, Rechsteiner M, Frick L, Böhm F,
Struckmann K, Egger M, Moch H, Heikenwalder M and Weber A:
Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer
Res. 21:1951–1961. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakamura T, Teramoto H, Tomita Y and
Ichihara A: L-proline is an essential amino acid for hepatocyte
growth in culture. Biochem Biophys Res Commun. 122:884–891. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Davies B and Fried M: The L19 ribosomal
protein gene (RPL19): Gene organization, chromosomal mapping, and
novel promoter region. Genomics. 25:372–380. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tam S, Clavijo A, Engelhard EK and
Thurmond MC: Fluorescence-based multiplex real-time RT-PCR arrays
for the detection and serotype determination of foot-and-mouth
disease virus. J Virol Methods. 161:183–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SC, Zeng C, Tschudy-Seney B, Nguyen
NT, Eun JR, Zhang Y, Ramsamooj R, Zhang Y, Zhao M, Theise ND, et
al: Clonogenically culturing and expanding CD34+ liver cancer stem
cells in vitro. Stem Cells Dev. 24:1506–1514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mu X, Español-Suñer R, Mederacke I, Affò
S, Manco R, Sempoux C, Lemaigre FP, Adili A, Yuan D, Weber A, et
al: Hepatocellular carcinoma originates from hepatocytes and not
from the progenitor/biliary compartment. J Clin Invest.
125:3891–3903. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao X, Parpart S, Takai A, Roessler S,
Budhu A, Yu Z, Blank M, Zhang YE, Jia HL, Ye QH, et al: Integrative
genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+)
AFP(+) hepatocellular carcinoma. Oncogene. 34:5095–5104. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Benzoubir N, Mussini C, Lejamtel C, Dos
Santos A, Guillaume C, Desterke C, Samuel D, Bréchot C, Bourgeade
MF and Guettier C: Gamma-smooth muscle actin expression is
associated with epithelial-mesenchymal transition and stem-like
properties in hepatocellular carcinoma. PLoS One. 10:e01305592015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao Y, Ruan B, Liu W, Wang J, Yang X,
Zhang Z, Li X, Duan J, Zhang F, Ding R, et al: Knockdown of CD44
inhibits the invasion and metastasis of hepatocellular carcinoma
both in vitro and in vivo by reversing epithelial-mesenchymal
transition. Oncotarget. 6:7828–7837. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng GM and To KK: Adverse cell culture
conditions mimicking the tumor microenvironment upregulate ABCG2 to
mediate multidrug resistance and a more malignant phenotype. ISRN
Oncol. 2012:7460252012.PubMed/NCBI
|
|
26
|
Menendez JA, Oliveras-Ferraros C, Cufi S,
Corominas-Faja B, Joven J, Martin-Castillo B and Vazquez-Martin A:
Metformin is synthetically lethal with glucose withdrawal in cancer
cells. Cell Cycle. 11:2782–2792. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao J, Qian F, Tchabo N,
Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB,
Morrison CD and Odunsi K: Ovarian cancer spheroid cells with stem
cell-like properties contribute to tumor generation, metastasis and
chemotherapy resistance through hypoxia-resistant metabolism. PLoS
One. 9:e849412014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu CP, Wang AQ, Zhang HH, Wan XS, Yang
XB, Chen SG and Zhao HT: Research progress and prospects of markers
for liver cancer stem cells. World J Gastroenterol. 21:12190–12196.
2015. View Article : Google Scholar : PubMed/NCBI
|
